Cargando…
Leveraging reimbursement strategies to guide value-based adoption and utilization of medical AI
With the increasing number of FDA-approved artificial intelligence (AI) systems, the financing of these technologies has become a primary gatekeeper to mass clinical adoption. Reimbursement models adapted for current payment schemes, including per-use rates, are feasible for early AI products. Alter...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364287/ https://www.ncbi.nlm.nih.gov/pubmed/35948612 http://dx.doi.org/10.1038/s41746-022-00662-1 |